Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate add-on therapy in familial dysbetalipoproteinemia
2014-000524-26Phase 4Active
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bezafibrate in dysbetalipoproteinemia (DBL) (2 arms), sponsored by University Medical Center Utrecht. Started Apr 2015; status: active.
02
Drugs
bezafibrate
03
Conditions
dysbetalipoproteinemia (DBL)
Beyond the preview
Go deeper on 2014-000524-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000524-26.